Metagenomi revenue was $30.91M for the trailing 12 months ending Sep 30, 2025, with N/A growth year over year. Quarterly revenue for the quarter (Q3 2025) ending on Sep 30, 2025 was $8.7M, up 1.7% from last quarter. For the last reported fiscal year 2024 ending Dec 31, 2024, MGX annual revenue was $52.3M, with 16.8% growth year-over-year.
MGX past revenue growth
How has MGX's revenue growth performed historically?
On Invalid Date, Metagenomi (NASDAQ: MGX) reported Q3 2025 revenue of $8.66 million up 24.8% year over year. In the same quarter last year, Metagenomi's revenue was $11.51 million.
What was Metagenomi's revenue in 2024?
Metagenomi's annual revenue for the twelve months ending Dec 31, 2024 was $52.30 million, a 16.84% increase year over year.
How much does Metagenomi make in a day?
Based on Metagenomi annual revenue for the past three years, MGX makes an average of $104,338.81 per day.
What was Metagenomi's annual revenue growth in the past year?
As of Q4 2025, Metagenomi's revenue has grown -43.88% year over year. This is 338.73 percentage points lower than the US Biotechnology industry revenue growth rate of 294.85%. Metagenomi's revenue in the past year totaled $30.91 million.
How much does Metagenomi make in a year?
Metagenomi's revenue by year for the past three years is:
Metagenomi's revenue for the twelve months ending Dec 31, 2024 was $52.30 million, a 16.84% increase year over year.
Metagenomi's annual revenue for Dec 31, 2023 was $44.76 million, a 160.21% increase from 2022.
Metagenomi's annual revenue for 2022 was $17.20 million, a 6,978.19% increase from 2021.
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.
Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.